# Presentation: 920054

## American Red Cross:  Evolution ofvCJD Donor Deferral Criteria and Blood Supply

- Peter L. Page, MD
- Senior Medical Officer
- Biomedical Headquarters
- TSEAC February 20, 2003

## Background 1

***March 2000:***  ARC initiated first vCJD deferrals
***Early 2001:***  ARC developed vCJD geographic donor deferral criteria, based upon concern and uncertainty about upcoming evolution of epidemic, stating policy would be reconsidered annually and as new data accrue

## Background 2

***October 2001:***  ARC implemented its initial deferral criteria
***January 2002:***  FDA issues final guidance to take effect 06/02 and 11/02
***Spring 2002:***  ARC decides to relax criteria regarding presence in the UK after 1996 (actual implementation TBD in 2003)

## Quick-reference summary of vCJD-related geographic donor deferral criteria as of 1/9/02

- 2	Albania, Austria, Belgium, Bosnia-Herzegovina, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Germany, Greece, Hungary, Republic of Ireland, Italy, Liechtenstein, Luxembourg, Macedonia, Netherlands, Norway, Poland, Portugal, Romania, Slovak Republic, Slovenia, Spain, Sweden, Switzerland, Federal Republic of Yugoslavia.
- 3	Germany, Italy, Netherlands, Switzerland, Austria, Belgium, Spain, Republic of Ireland, Portugal, Denmark, Luxembourg and Liechtenstein

**Agency**

**In Effect:**

**UK**

**France**

**Europe Other Than France**

**Other Countries**

**Special Rules for US Military Base Personnel**

**FDA**

- 11/99-5/02

- 6 months, 1980-1996

- None

- None

- None

- None

**ARC**

**10/01 forward**

- 3 months, 1980-present

- 6 months,1980-present

- 6 months,1980-present, all countries

- Gibraltar and Falklands same as UK; Oman same as Europe

- Same as country in which military base resides. NOTE: This implies there is not deferral for military staff on bases in Turkey

**DoD**

- Same as FDA

- Same as FDA

- Same as FDA

- Same as FDA

- Same as FDA

- 6 months from 1980-1996 for bases anywhere in Europe or Turkey

**Hema Quebec**

- 9/01 forward

- 1 month,1980-present

- 3 months,
- 1980-present

- 6 months, Western Europe only3

- None

- None

**CBS**

- 10/01 forward

- 3 months,1980-present

- 3 months,
- 1980-present

- 5 years, 1980-present, Western Europe only3

- None

- None

## 1. UK Deferral Criteria

- Current ARC criteria:	 3 months, 1980-present
- Upcoming ARC criteria:	 3 months, 1980-1996
- FDA criteria:	 3 months, 1980-1996
*ARC to* change to FDA’s criteria (cut off at end of 1996)
***Rationale:***  Food chain controls implemented in UK by 1996 are now (2002) deemed to have been effective and sufficient.
***Results:***
- ARC consistent with FDA on this issue
- Individuals’ presence in the UK after 1996, after food controls in place, would not effect eligibility

## 2. Rest of Europe Deferral Criteria

- Ongoing ARC criteria:	 6 months for all countries
- FDA criteria (11/02):	 5 years for most countries
***ARC Plan:*** To be re-evaluated in Spring ‘03
***Rationale:*** Continuing lack of active surveillance and effective food controls in some of those countries now better appreciated in 2002
***Results:***
- No operational change for ARC; avoid complexity of dealing with various U.S. bases

## Differences in vCJD geographic deferrals: Current and upcoming ARC and current FDA

**ARC**

**FDA**

- Oman included
- US Military bases in specified European countries

- Yes
- ‘80-present6 monthsWhole country

- 1.	3 months in UK from

- ‘80-Present
- ’80-’96*

- 2.	Time in Europe from 1980-present

- 6 months*(All European countries)*

- No
- ‘80-‘90 or -‘966 monthsOnly bases

- ‘80-‘96

- 5 years*(Some European countries)*

- *Date of change TBD in 2003

## ARC Experience

- Donor deferrals*, & blood collections vs. goal
- Blood distribution & inventory

- *DONOR DEFERRALS = PRESENTING VOLUNTEERS TURNED AWAY FROM DONATION--WHICH DOES _NOT_ INCLUDE INDIVIDUALS WHO DO NOT PRESENT AT ALL,  HAVING HEARD ELSEWHERE THAT THEY WOULD BE TURNED AWAY.

## vCJD Deferrals in October 2001

**Percent Deferred re vCJD**
*By Day*

- 6 months UK
- Bovine insulin

- 3 months UK
- 6 months rest of Europe
- Bovine insulin

**2001**

## vCJD Deferrals September 01– March 02

- vCJD Deferrals September 01– March 02

**Percent Deferred**
*By Week*

**2001**

**2002**

## American Red Cross Blood Services Regions by Region Code and Customer Business Unit (CBU)

**Puerto Rico**

- 84

- 6

- 7

- 20

- 21

- 17

- 9

- 2

- 49

- 55

- 11

- 32

- 40

- 38

- 18

- 4

- 19

- 41

- 26

- 3

- 36

- 24

- 1

- 33

- 29

- 22

- 53

- 30

- 27

- 35

- 42

- 16

- 50

- 13

- 2

- 54

***South Central CBU***

***Western CBU***

***North Central CBU***

***North Atlantic CBU***

## vCJD Specific Donor Deferral Rates by RegionFor 03/01 and 10/15-12/14/01

- vCJD Specific Donor Deferral Rates by Region*For 03/01 and 10/15-12/14/01*

- North Atlantic

- North Central

- South Central

- Western

**Region Code**

**CBU:**

**3/01**	≥ 6 months UK, in place for 12 months
**10/15-12/14/01**	≥ 3 months UK, ≥ 6 months Europe, newly implemented

## vCJD Specific Donor Deferral Rates by RegionFor 10/15-12/14/01, 3/02 and 7-12/02

- vCJD Specific Donor Deferral Rates by Region*For 10/15-12/14/01, 3/02 and 7-12/02*

- North Atlantic

- North Central

- South Central

- Western

**Region Code**

**CBU:**

**3/01**	≥ 6 months UK, in place for 12 months
**10/15-12/14/01**	≥ 3 months UK, ≥ 6 months Europe, newly implemented
**3/02**	≥ 3 months UK, ≥ 6 months Europe, in place for 6 months

## Summary:vCJD Deferrals by Region and Time

**Time Period**

**Number of Donors Deferred re vCJD per Month**

**March 01**

**361**

**10/15 – 12/14/01***

**5,631**

**March 02**

**ARC**

**FDA**

**Range**

**Average**

**Regional Donor vCJD Deferral Rate**

**0.00% - 0.18%**

**0.06%**

**0.21% - 1.45%**

**0.88%**

**0.25% - 1.15%**

**0.62%**

**3,764**

- *New criteria started 10/15/01
- **Lessening of UK deferrals not after implemented

**December 02****

**0.08% - 0.83%**

**0.38%**

**2,108**

## Deferrals and Collections

**Deferral Rate**
**All Donors, All Reasons**
*By Month*

**WB Allogeneic Collections**
*By Month*

**August 2000**
**Switch from ear to finger sample, +4.5% deferral for hemoglobin**

## Distribution and Inventory

**Average Net Daily Distribution**
*By Month*

**Average Daily Inventory**
*By Month*

## Summary

- When anticipated and planned for, new donor deferral criteria should be accommodated by increased donor recruitment and collection efforts, albeit expensive
- After the increase in deferrals from a new measure, there is culling, and the deferral rate for that reason then drops
- Deferral for TSE concerns is only one of several recently added deferral criteria, each of which increases the cost of donor recruitment and collection to try to make up for it
- More regular volunteer blood donations continue to be needed to prevent seasonal shortages and to develop a reserve for unanticipated occurrences